Related Experiment Video
Updated: May 12, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Gossypol induces apoptosis in ovarian cancer cells through oxidative stress
Jia Wang1, Lixu Jin, Xiaoyu Li
1The Second Affiliated Hospital of Wenzhou Medical College, Wenzhou, China.
Abstract:
In the present work, metabolomic and redox proteomic analyses were carried out on an untreated- and gossypol-treated ovarian cancer cell line, SKOV3. Gossypol treatment resulted in cell death through oxidative stress. Metabolite analysis showed that gossypol induces a decrease of the cellular levels of GSH, aspartic acid, and FAD. Using a combination of double labeling and LC-MS-MS, we identified changes in thiol-redox states of 545 cysteine-containing peptides from 356 proteins. The frequently occurring amino acid residue immediately before or after the cysteine in these peptides is the non-polar and neutral leucine, valine, or alanine. These redox sensitive proteins participate in a variety of cellular processes. We have characterized the redox-sensitive cysteine residues in PKM2, HSP60, malate dehydrogenase and other proteins that play important roles in metabolism homeostasis and stress responses. The three cysteine residues of HSP60 exhibit different responses to gossypol treatment: an increase of thiol/disulfide ratio for the Cys447 residue due to a decrease of the cellular GSH level, and a decrease of thiol/disulfide ratios for Cys442 and Cys237 residues due to oxidation and sulfation. This study suggests that thiol/disulfide ratios are dependent on the level of cellular GSH. Our data provide a valuable resource for deciphering the redox regulation of proteins and for understanding gossypol-induced apoptosis in ovarian cancer cells.
Insights
Gossypol induces ovarian cancer cell death via oxidative stress, altering cellular glutathione (GSH) levels and redox states of key proteins. This study reveals gossypol
Area of Science:
- Biochemistry
- Cell Biology
- Proteomics
Background:
- Ovarian cancer remains a significant health challenge.
- Gossypol is a potential anti-cancer agent.
- Oxidative stress plays a role in cancer cell death.
Purpose of the Study:
- To investigate the effects of gossypol on ovarian cancer cells at the metabolomic and redox proteomic levels.
- To identify specific proteins and metabolic pathways affected by gossypol treatment.
- To elucidate the mechanism of gossypol-induced apoptosis in ovarian cancer.
Main Methods:
- Metabolomic analysis of untreated and gossypol-treated SKOV3 ovarian cancer cells.
- Redox proteomics using double labeling and LC-MS-MS to identify changes in cysteine thiol-redox states.
- Analysis of metabolite levels, including glutathione (GSH), aspartic acid, and FAD.
- Characterization of redox-sensitive cysteine residues in key proteins like PKM2, HSP60, and malate dehydrogenase.
Main Results:
- Gossypol treatment induced cell death in SKOV3 cells through oxidative stress.
- Gossypol decreased cellular levels of GSH, aspartic acid, and FAD.
- Redox proteomic analysis identified altered thiol-redox states in 545 cysteine-containing peptides from 356 proteins.
- Specific cysteine residues in HSP60 showed differential responses to gossypol, influenced by GSH levels and oxidation/sulfation.
- Redox-sensitive proteins identified are involved in metabolism and stress responses.
Conclusions:
- Gossypol induces apoptosis in ovarian cancer cells via oxidative stress.
- Cellular GSH levels are critical in regulating thiol/disulfide ratios and protein redox states.
- The study provides insights into gossypol's mechanism of action and identifies potential therapeutic targets.
Related Concept Videos
Apoptosis
The Intrinsic Apoptotic Pathway
Oogenesis
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
